Vitamin D Not Associated With Risk For Less Common Cancers, Study Finds
ASCO Recommends Aromatase Inhibitors As Adjuvant For Some Breast Cancer
Half Of Women Complete Full Hormone Therapy Regimen
Surveillance Colonoscopy Cost-Effective For High-Risk
Surveillance Treatment Option For Low-Risk Prostate Cancer
Toxicity, Non-Cancer Deaths Increase With Combo Therapy
Time Spent Sitting Associated With Total Mortality, Study Finds
Cancer Mortality Rate Down 1.3 Percent, ACS Report Finds
NCI-Approved Clinical Trials
Trending Stories
- CBER Director Vinay Prasad sidelined staff to jettison Moderna’s mRNA flu shot
- Lou Weisbach tells us about his plan to raise $750 billion for the American Center for Cures
- On Day 2 as director of NYU Perlmutter, Anirban Maitra talks about the advantages of running a matrix cancer center
- Mail-out colorectal cancer screening programs extend, rather than replace, clinical care
- After a brief government shutdown, FY26 funding bill is signed into law
NIH gets $415M raise, NCI gets $128M more, CDMRP funding largely restored - Spending bill passed by the House gives NIH $415M raise, NCI gets $128M
Legislation caps proportion of NIH grants to receive multiyear funding; indirect costs remain untouched









